Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Settles Patent Infringement Suit with Caliper

NEW YORK, Nov. 4 (GenomeWeb News) - Molecular Devices today said it has settled a patent infringement lawsuit filed by Caliper Technologies in 2002 involving Molecular Devices' IMAP kinase assay products.

Under the terms of the settlement, Molecular Devices has agreed to pay Caliper a one-time licensing fee as well as royalties based on future sales of IMAP products.

Further details of the settlement were not disclosed.

The lawsuit alleged that Molecular Devices' IMAP assay products infringed Caliper's US Patent Nos. 6,287,774 and 6,472,141, which cover methods and systems for performing assays in which the reaction product has a different charge than the substrate. The product or substrate is bound to a polyionic component, and the binding is detected by conventional methods, including fluorescence polarization.

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.